• LAST PRICE
    0.2900
  • TODAY'S CHANGE (%)
    Trending Up0.0050 (1.7544%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.2900 / 0.2850
  • Day Range
    Low 0.2850
    High 0.2900
  • 52 Week Range
    Low 0.1400
    High 0.3800
  • Volume
    25,000
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.285
TimeVolumeTLT
09:32 ET120000.29
10:06 ET30000.285
12:28 ET35000.285
12:51 ET15000.29
02:18 ET45000.29
03:44 ET5000.29
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaTLT
Theralase Technologies Inc
63.6M
-14.9x
---
CanadaMIR
MedMira Inc
57.7M
-16.9x
---
CanadaBLO
Cannabix Technologies Inc
47.2M
-12.3x
---
CanadaPINK
Perimeter Medical Imaging AI Inc
61.6M
-1.9x
---
CanadaTRUE
Treatment.com AI Inc
26.5M
-2.3x
---
CanadaVPT
VentriPoint Diagnostics Ltd
22.6M
-4.1x
---
As of 2024-11-22

Company Information

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

Contact Information

Headquarters
41 Hollinger RoadTORONTO, ON, Canada M4B 3G4
Phone
416-699-5273
Fax
416-699-5250

Executives

Chairman of the Board, President, Chief Executive Officer
Roger Dumoulin-White
Chief Financial Officer, Director
Kristina Hachey
Chief Scientific Officer, Director
Arkady Mandel
Independent Director
Guy Anderson
Independent Director
Randy Bruder

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$64.7M
Revenue (TTM)
$920.6K
Shares Outstanding
223.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.36
EPS
$-0.02
Book Value
$0.01
P/E Ratio
-14.9x
Price/Sales (TTM)
70.3
Price/Cash Flow (TTM)
---
Operating Margin
-478.72%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.